Get the Stockscreener App
1.45
0.00%
0.00
Lucid Diagnostics Inc stock is traded at $1.45, with a volume of 508.63K.
It is up +0.00% in the last 24 hours and up +20.83% over the past month.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
See More
Previous Close:
$1.45
Open:
$1.47
24h Volume:
508.63K
Relative Volume:
0.40
Market Cap:
$190.09M
Revenue:
$4.35M
Net Income/Loss:
$-45.53M
P/E Ratio:
-1.3426
EPS:
-1.08
Net Cash Flow:
$-44.79M
1W Performance:
-0.68%
1M Performance:
+20.83%
6M Performance:
+5.07%
1Y Performance:
+11.54%
1-Day Range:
$1.44
$1.49
1-Week Range:
$1.38
$1.495
52-Week Range:
$0.9495
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Name
Lucid Diagnostics Inc
Sector
Industry
Phone
212 949 4319
Address
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.45 | 190.09M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-21 | Initiated | Ascendiant Capital Markets | Buy |
| Nov-08-21 | Initiated | BTIG Research | Buy |
| Nov-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-08-21 | Initiated | Needham | Buy |
Lucid Diagnostics Inc Stock (LUCD) Latest News
Breakouts Watch: Can Lucid Diagnostics Inc expand into new marketsVolume Spike & Weekly Momentum Stock Picks - baoquankhu1.vn
LUCD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to "Hold" at Wall Street Zen - MarketBeat
LUCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Downgrade Watch: Is Lucid Diagnostics Inc likely to announce a buybackDay Trade & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Lucid Diagnostics CEO granted 2.17M restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) receives 123,000-share restricted stock grant - Stock Titan
123K-share equity grant to Lucid Diagnostics (LUCD) director Debra White vests 2029 - Stock Titan
Lucid director granted 123,000 restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) awarded 123,000 restricted shares - Stock Titan
Director at Lucid Diagnostics (LUCD) granted 123K restricted shares - Stock Titan
[Form 4] Lucid Diagnostics Inc. Insider Trading Activity - Stock Titan
Director at Lucid Diagnostics (NASDAQ: LUCD) receives 123,000-share restricted stock grant - Stock Titan
Lucid Diagnostics (LUCD) CFO granted 470,000 restricted shares vesting in 2029 - Stock Titan
Lucid Diagnostics (LUCD) COO awarded 620,000 restricted shares in Form 4 filing - Stock Titan
Lucid Diagnostics (LUCD) awards 300,000 restricted shares to General Counsel - Stock Titan
Aberdeen Group plc Invests $2.53 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Aug Decliners: Is Lucid Diagnostics Inc likely to announce a buybackJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn
What’s the fair value of Lucid Diagnostics Inc. stock2025 Winners & Losers & Low Risk High Reward Ideas - mfd.ru
Surprises Report: Can Lucid Diagnostics Inc be recession proofWeekly Trade Review & Precise Trade Entry Recommendations - baoquankhu1.vn
Will Lucid Diagnostics Inc. stock remain a Wall Street favoriteQuarterly Market Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - MarketBeat
Can Lucid Diagnostics Inc. lead its sector in growthWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
Stock Analysis: What is Lucid Diagnostics Incs valuation compared to sector2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 20.0% in January - MarketBeat
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Is Lucid Diagnostics Inc. gaining market share2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
Retail Surge: Can Lucid Diagnostics Inc expand into new markets2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Summary: Can Lucid Diagnostics Inc expand into new marketsMarket Growth Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Lucid Diagnostics Inc. (LUCD) stock: slides after early spike despite major VA contract win - parameter.io
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Lucid Diagnostics Wins U.S. Department of Veterans Affairs Contract for EsoGuard - marketscreener.com
Lucid Diagnostics Inc Stock (LUCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):